Real-time enrollment status for this ipf clinical trial
Current Status
Active, Not Recruiting
Checked: July 21, 2026 at 5:30 AM UTC
| NCT Number | NCT05389215 |
| Recruiting Status | Active, Not Recruiting |
| Condition | IPF |
| Phase | PHASE2 |
| Target Enrollment | 102 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Daewoong Pharmaceutical Co. LTD. |
| Last Updated on CT.gov | July 16, 2026 (5 days ago) |
As of July 21, 2026: Clinical trial NCT05389215 is currently active_not_recruiting participants. This phase2 study for ipf is not currently accepting new participants at 20 locations across the United States. The study is sponsored by Daewoong Pharmaceutical Co. LTD.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05389215 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05389215 was last updated 5 days ago (July 16, 2026). HelloStudys verifies this status automatically.